DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of Cardiovascular Electrophysiology

SEPTEMBER 7, 2023

Methods To ascertain the role of AADs to treat PVC-CM; whether they are indicated to treat PVC-CM, and if so, when, we interrogated PubMed and other search engines for English language publications with key words premature ventricular complexes (PVCs), cardiomyopathy, anti-arrhythmic drugs, catheter ablation, and pharmacological agents.

Cardiomyopathy 40

Cardiomyopathy Pharmacology Coronary Artery Disease Ablation 40

Journal of Cardiovascular Electrophysiology

JANUARY 19, 2024

episodes annually) that remained unresponsive to clinical and pharmacological interventions, underwent CNA, divided into two groups: ECVS and NoECVS, consisting of 34 and 14 cases, respectively. Method A cohort of 48 patients, predominantly female (56.3%), suffering from recurrent syncope (5.1 ± 2.5

Outcomes 40

Outcomes Atrial Fibrillation Pharmacology Pacemaker 40

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

If the rhythm converts and then reverts to tachycardia with either adenosine or electricity, Neither one of those modalities should be attempted until some longer acting pharmacological solution is given. Admission and referral to electrophysiology is always indicated. WPW does not always have delta waves on the baseline ECG.

Tachycardia 52

Tachycardia Heart Disease Dysrhythmia Ablation 52

HeartRhythm

APRIL 30, 2024

In light of these data, we sought to reappraise of the electrophysiological effect of compounds proposed for the treatment of TS1. Using electroanatomic mapping (EAM) we discovered cardiac activation delay, which creates the milieu for functional reentrant ventricular arrhythmias.

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology Electrophysiology Arrhythmia 40

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

Dr. Smith's ECG Blog

APRIL 8, 2016

Crit Care Med 1991; 19:694) Concentrated Potassium Chloride Infusions in Critically Ill Patients with Hypokalemia The Journal of Clinical Pharmacology. Furthermore, these results were independent of the patient's underlying renal function or associated diuretic administration.

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Journal of Clinical Investigation - Cardiology

FEBRUARY 17, 2025

Using a mix of techniques, including animal behavioral models, electrophysiology on mouse and human dorsal root ganglion (DRG) neurons, and elegant biochemical pharmacology, the authors demonstrated that this therapeutic target might more safely manipulate NGF signaling to achieve pain alleviation.

Pharmacology 98

Pharmacology Electrophysiology Innovation 98

Frontiers in Cardiovascular Medicine

JANUARY 23, 2025

The primary electrophysiological mechanism of atrial fibrillation (AF) maintenance is poorly defined. Electrophysiological alterations induced by anti-AF drugs before AF cardioversion may help delineate the mechanism of AF maintenance.

Atrial Fibrillation 52

Atrial Fibrillation Pharmacology Electrophysiology 52